↓ Skip to main content

Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies

Overview of attention for article published in European Journal of Epidemiology, June 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
3 news outlets
policy
4 policy sources
twitter
32 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
49 Mendeley
Title
Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies
Published in
European Journal of Epidemiology, June 2012
DOI 10.1007/s10654-012-9704-8
Pubmed ID
Authors

Jenny Hansson, Maria Rosaria Galanti, Maria-Pia Hergens, Peeter Fredlund, Anders Ahlbom, Lars Alfredsson, Rino Bellocco, Marie Eriksson, Johan Hallqvist, Bo Hedblad, Jan-Håkan Jansson, Peter Nilsson, Nancy Pedersen, Ylva Trolle Lagerros, Per-Olof Östergren, Cecilia Magnusson

Abstract

The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is common in Sweden and increasing elsewhere, is receiving increasing attention since considered a tobacco smoke "potential reduction exposure product". Snus delivers a high dose of nicotine with possible hemodynamic effects, but its impact on cardiovascular morbidity and mortality is uncertain. The aim of this study was to investigate whether snus use is associated with risk of and survival after acute myocardial infarction (AMI). Data from eight prospective cohort studies set in Sweden was pooled and reanalysed. The relative risk of first time AMI and 28-day case-fatality was calculated for 130,361 men who never smoked. During 2,262,333 person-years of follow-up, 3,390 incident events of AMI were identified. Current snus use was not associated with risk of AMI (pooled multivariable hazard ratio 1.04, 95 % confidence interval 0.93 to 1.17). The short-term case fatality rate appeared increased in snus users (odds ratio 1.28, 95 % confidence interval 0.99 to 1.68). This study does not support any association between use of snus and development of AMI. Hence, toxic components other than nicotine appear implicated in the pathophysiology of smoking related ischemic heart disease. Case fatality after AMI is seemingly increased among snus users, but this relationship may be due to confounding by socioeconomic or life style factors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 2 4%
Unknown 47 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Master 8 16%
Other 5 10%
Student > Bachelor 4 8%
Student > Ph. D. Student 4 8%
Other 9 18%
Unknown 9 18%
Readers by discipline Count As %
Medicine and Dentistry 20 41%
Nursing and Health Professions 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Agricultural and Biological Sciences 3 6%
Social Sciences 3 6%
Other 6 12%
Unknown 11 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2023.
All research outputs
#685,621
of 25,394,764 outputs
Outputs from European Journal of Epidemiology
#106
of 1,801 outputs
Outputs of similar age
#3,388
of 177,812 outputs
Outputs of similar age from European Journal of Epidemiology
#3
of 13 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,801 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,812 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.